JP6586450B2 - Allergen antibody and composition having the same - Google Patents

Allergen antibody and composition having the same Download PDF

Info

Publication number
JP6586450B2
JP6586450B2 JP2017243883A JP2017243883A JP6586450B2 JP 6586450 B2 JP6586450 B2 JP 6586450B2 JP 2017243883 A JP2017243883 A JP 2017243883A JP 2017243883 A JP2017243883 A JP 2017243883A JP 6586450 B2 JP6586450 B2 JP 6586450B2
Authority
JP
Japan
Prior art keywords
antibody
allergen
allergens
antigen
egg yolk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017243883A
Other languages
Japanese (ja)
Other versions
JP2018080177A (en
Inventor
康浩 塚本
康浩 塚本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OSTRICH PHARMA KK
Original Assignee
OSTRICH PHARMA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OSTRICH PHARMA KK filed Critical OSTRICH PHARMA KK
Priority to JP2017243883A priority Critical patent/JP6586450B2/en
Publication of JP2018080177A publication Critical patent/JP2018080177A/en
Application granted granted Critical
Publication of JP6586450B2 publication Critical patent/JP6586450B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明はハウスダストを抗原として得た抗体およびその組成物と抗体を有する化粧品に係るものである。   The present invention relates to an antibody obtained from house dust as an antigen, a composition thereof, and a cosmetic having the antibody.

人の居住空間には様々なアレルゲンが存在する。花粉アレルゲン、イヌ・ネコのアレル
ゲン、ダニアレルゲン、ハウスダストのアレルゲンなどである。これらは、アレルギー性
疾患や皮膚疾患に関与していると言われている。イヌ・ネコ、ダニ、ハウスダストのアレ
ルゲンは喘息やアトピー性皮膚炎を誘発すると考えられている。
There are various allergens in human living space. These include pollen allergens, dog and cat allergens, mite allergens and house dust allergens. These are said to be involved in allergic diseases and skin diseases. Allergens in dogs, cats, ticks and house dust are thought to induce asthma and atopic dermatitis.

特許文献1には、ヒノキ花粉アレルゲンに対する抗体が開示されている。   Patent Document 1 discloses an antibody against cypress pollen allergen.

国際公開第2012/105541号International Publication No. 2012/105541

特許文献1のように、抗原が1つの場合は、これに対する抗体を記載したものはある。
しかし、生活部屋内で生じるアレルギーの場合は、抗原がダニアレルゲン、イヌ・ネコア
レルゲン等複数に渡る場合がある。これら全てのそれぞれに対応する抗体を産生するのは
手間がかかる。これらに1の抗体で効果があるものの報告はなかった。
As in Patent Document 1, in the case where there is one antigen, there are those that describe antibodies against this.
However, in the case of allergies occurring in the living room, there are cases where the antigens are spread over a plurality of mite allergens, dogs and cat allergens. It takes time to produce antibodies corresponding to all of these. There was no report on the effectiveness of 1 antibody.

また、皮膚に生じる疾患の内、細菌が係る物に対して疾患を緩和させることができる抗
体の報告もなかった。
In addition, there has been no report of an antibody capable of alleviating the disease against bacteria related to the diseases occurring in the skin.

本発明は上記の課題に鑑みて想到されたもので、皮膚に生じる疾患の内、緑膿菌によって生じる皮膚の保湿性を低下させ、皮膚の老化やアトピー性皮膚炎を緩和させることが期待できる抗体である。   The present invention has been conceived in view of the above problems, and is expected to reduce skin moisturization caused by Pseudomonas aeruginosa among diseases occurring in the skin and relieve skin aging and atopic dermatitis. It is an antibody.

本発明に係る抗体は、複数のアレルゲンを抗原として、ダチョウの雌に接種させ、その雌ダチョウから得た卵から得たもので、接種させたほぼ全ての抗原に対して吸着反応を有する。したがって、1つの抗体で生活空間でのアレルゲンを不活性化させることができる。   The antibody according to the present invention is obtained by inoculating an ostrich female with a plurality of allergens as antigens, and obtained from an egg obtained from the female ostrich, and has an adsorption reaction to almost all of the inoculated antigens. Therefore, allergens in living space can be inactivated with one antibody.

これらの抗体をスプレー、化粧品(皮膚ケア商品)、噴霧剤、医薬品に含有させること
で、アレルゲンと抗原抗体反応をおこさせ中和させることで、アレルギー性を低下させる
ことができ、アレルギー性疾患の緩和を図ることができる。また、これらの抗体をエアコ
ンのフィルターやマスクのフィルターに担持させてもよい。また、スプレーや噴霧剤は人
が噴霧するだけでなく、エアコン等の機械から噴霧されてもよい。
By including these antibodies in sprays, cosmetics (skin care products), sprays, and pharmaceuticals, allergens can be reduced by causing antigen-antibody reactions with allergens and neutralizing them. Mitigation can be achieved. Further, these antibodies may be carried on an air conditioner filter or a mask filter. Further, sprays and sprays may be sprayed not only by a person but also from a machine such as an air conditioner.

以下本発明に係る抗体について説明する。なお、以下の説明は本発明の一実施形態を示
すものであり、本発明の趣旨を逸脱しない範囲で、以下の実施形態および実施例は改変さ
れてもよい。
Hereinafter, the antibody according to the present invention will be described. The following description shows one embodiment of the present invention, and the following embodiment and examples may be modified without departing from the spirit of the present invention.

本発明で使用できる抗原は、複数種類を混在させることが可能であり、ダニアレルゲン
各種やイヌアレルゲン、ネコアレルゲンといった特定のアレルゲンや、これらの総合物と
してハウスダストアレルゲンを使用してもよい。ハウスダストアレルゲンは、生活空間内
から収集したアレルゲンと考えられる集合物である。したがって、ハウスダストアレルゲ
ンには、ダニアレルゲンやイヌアレルゲン、ネコアレルゲンが含まれていてもよい。ハウ
スダストアレルゲンは、ハウスダストに係るアレルゲンであって、複数のアレルゲンの集
合物と言ってもよい。
A plurality of types of antigens that can be used in the present invention can be mixed, and various types of mite allergens, specific allergens such as dog allergens and cat allergens, and house dust allergens may be used as a total thereof. A house dust allergen is an aggregate considered as an allergen collected from within the living space. Therefore, the house dust allergen may contain mite allergens, dog allergens, and cat allergens. The house dust allergen is an allergen related to house dust, and may be referred to as an aggregate of a plurality of allergens.

また、抗原には緑膿菌ホモジネート液を用いることもできる。緑膿菌は、セラミダーゼ
を産生する菌である。このセラミダーゼは、皮膚のバリア機能を維持するための分子であ
るセラミドを分解する酵素である。したがって、セラミドが分解され欠乏すると、皮膚の
バリア機能を低下させ、皮膚の保湿性を低下させ、皮膚の老化やアトピー性皮膚炎の原因
にもなる。
Moreover, a Pseudomonas aeruginosa homogenate liquid can also be used for an antigen. Pseudomonas aeruginosa is a bacterium that produces ceramidase. This ceramidase is an enzyme that degrades ceramide, which is a molecule for maintaining the barrier function of the skin. Therefore, when ceramide is decomposed and deficient, the barrier function of the skin is lowered, the moisture retention of the skin is lowered, and it causes aging of the skin and atopic dermatitis.

セラミドの欠乏は、セラミドの産生低下とセラミドの分解促進が原因である。また、緑
膿菌などの皮膚細菌からのセラミダーゼによってセラミドの分解が過剰に起こってしまい
、皮膚の保湿性低下と老化、アトピー誘発につながるとも考えられる。
Ceramide deficiency is caused by reduced production of ceramide and accelerated degradation of ceramide. In addition, it is considered that ceramide is excessively decomposed by ceramidase from skin bacteria such as Pseudomonas aeruginosa, leading to reduced skin moisture retention, aging, and induction of atopy.

緑膿菌ホモジネート液に対する抗体は、後述する実施例で示すように、緑膿菌だけでな
く緑膿菌が産生するセラミダーゼへも結合する。したがって、緑膿菌の増殖が抑制される
とともに、セラミダーゼの活性も阻害され、セラミドの分解が抑制さる。したがって、セ
ラミドが維持され、結果皮膚の環境は良くなると考えられる。
The antibody against Pseudomonas aeruginosa homogenate binds not only to Pseudomonas aeruginosa but also to ceramidase produced by Pseudomonas aeruginosa as shown in the examples described later. Therefore, the growth of Pseudomonas aeruginosa is suppressed, the activity of ceramidase is also inhibited, and the degradation of ceramide is suppressed. Therefore, ceramide is maintained, and as a result, the skin environment is considered to be improved.

本発明は鳥類の雌を用いる。鳥類であれば特に制限はない。しかし、ダチョウは1つの
ロットで多くの抗体が取れるので量産に好適である。
The present invention uses avian females. If it is birds, there will be no restriction | limiting in particular. However, ostriches are suitable for mass production because many antibodies can be obtained in one lot.

本発明に係る抗体は、抗体自体をアレルゲンに付与することでアレルゲンとしての効果
を低減させることができる。付与の仕方は、液体に含ませて霧状に散布してもよいし、エ
アゾル(気体の分散系)と共に散布してもよい。したがって、消臭剤、芳香剤に含ませて
もよい。また、緑膿菌を抗原として用いた場合は、抗体を皮膚に直接塗布することができ
る。また、ローションや化粧品に含ませてもよい。また、エアコンやマスクのフィルター
に含ませることで吸気中のアレルゲンをキャッチするようにしてもよい。
The antibody which concerns on this invention can reduce the effect as an allergen by providing the antibody itself to an allergen. The method of application may be included in a liquid and sprayed in the form of a mist, or may be sprayed together with an aerosol (gas dispersion system). Therefore, you may include in a deodorizer and an aromatic. When Pseudomonas aeruginosa is used as an antigen, the antibody can be directly applied to the skin. It may also be included in lotions and cosmetics. Moreover, you may make it catch the allergen in inhalation by including in the filter of an air conditioner or a mask.

したがって、本発明に係る抗体は、組成物の1成分として利用してもよい。組成物とし
ては、皮膚保湿用化粧品、老化防止用化粧品、アトピー用化粧品、ならびにそれらに相当
する医薬品等が挙げられる。
Therefore, the antibody according to the present invention may be used as one component of the composition. Examples of the composition include skin moisturizing cosmetics, anti-aging cosmetics, atopy cosmetics, and pharmaceuticals corresponding thereto.

<ダチョウ、ニワトリ、ウズラを用いて作製した卵黄抗体のダニアレルゲンに対する反
応性>
ダニアレルゲンに対する抗体を以下のようにし作製した。成熟したメス鳥(ダチョウ、
ニワトリ、ウズラ)を用いた。ダニアレルゲン(Dfb,Dpb,Dff,Dpf)50
μgをフロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各
抗原を個別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニ
ワトリもウズラも同量の抗原を接種したことになる。
<Reactivity to mite allergens of egg yolk antibody prepared using ostrich, chicken, quail>
An antibody against mite allergen was prepared as follows. Mature female bird (ostrich,
Chicken, quail). Mite allergen (Dfb, Dpb, Dff, Dpf) 50
μg was mixed with 0.2 mL of Freund's complete adjuvant and the ostrich was first immunized. Each antigen was individually inoculated into 5 ostriches, 5 chickens and 5 quails. Ostriches, chickens and quails have been vaccinated with the same amount of antigen.

初回免疫後、2週目と4週目に50μgの抗原とフロイントの不完全アジュバントの混
和液を、各鳥に追加免疫した。初回免疫後8週目に得られた各鳥からの卵の卵黄より卵黄
抗体(IgY)を精製した。得られた卵黄抗体の反応性をELISA(Enzyme−L
inked Immuno Sorbent Assay)により検証した。
After the first immunization, each bird was boosted with a mixture of 50 μg of antigen and Freund's incomplete adjuvant at 2 and 4 weeks. The egg yolk antibody (IgY) was purified from the egg yolk of each bird obtained 8 weeks after the first immunization. The reactivity of the obtained egg yolk antibody was determined by ELISA (Enzyme-L
verified by Inked Immuno Sorbent Assay).

ELISAによる抗体のアレルゲンに対する反応性は以下のようにして調べた。96穴
ELISAプレートの各穴に各ダニアレルゲン10μgを別々に固層化した(室温で4時
間)。その後、ダチョウ抗体(各3羽のダチョウから得た卵黄からの抗体の混合物)、ニ
ワトリ抗体(各3羽のニワトリから得た卵黄からの抗体の混合物)、ウズラ抗体(各3羽
のウズラから得た卵黄からの抗体の混合物)の段階希釈液(原液は2mg/mL)を各穴
に滴下し、室温で1時間反応させ、洗浄後、各抗体に対するHRP標識2次抗体を室温で
1時間反応させた。
The reactivity of antibodies to allergens by ELISA was examined as follows. 10 μg of each mite allergen was separately solidified in each hole of a 96-well ELISA plate (4 hours at room temperature). Then ostrich antibody (mixture of antibodies from egg yolk obtained from each of three ostriches), chicken antibody (mixture of antibodies from egg yolk obtained from each of three chickens), quail antibody (obtained from three quails each) A mixture of antibodies from the egg yolks) was added dropwise to each well and reacted at room temperature for 1 hour. After washing, the HRP-labeled secondary antibody for each antibody was reacted at room temperature for 1 hour. I let you.

十分な洗浄後、ペルオキシダーゼ用発色キット(S−Bio SUMILON)を用い
てプレートリーダーにて吸光度(450nm)を測定した。免疫前の各鳥種の卵黄抗体の
2倍以上の吸光度値を示す最大希釈倍率をELISA値として示した。結果を表1に示す
After sufficient washing, absorbance (450 nm) was measured with a plate reader using a peroxidase coloring kit (S-Bio SUMILON). The maximum dilution factor showing the absorbance value of 2 times or more of the yolk antibody of each bird species before immunization was shown as the ELISA value. The results are shown in Table 1.

ダチョウ、ニワトリ、ウズラにダニアレルゲン(Dfb,Dpb,Dff,Dpf)を
それぞれ免疫することで、高感度の卵黄抗体が作製されることが判明した。特に、各鳥種
には同量の抗原を免疫したのにもかかわらず、巨大なダチョウが最も反応性が高い抗体が
産生された。つまり、ダチョウを使うと少量の抗原でも高感度の抗体が産生できる。
It became clear that highly sensitive egg yolk antibodies were produced by immunizing ostriches, chickens, and quails with mite allergens (Dfb, Dpb, Dff, Dpf). In particular, despite the immunization of each bird species with the same amount of antigen, giant ostriches produced the most reactive antibodies. In other words, ostriches can produce highly sensitive antibodies with a small amount of antigen.

<ダチョウ、ニワトリ、ウズラにハウスダストアレルゲンを免疫して作製した卵黄抗体
の反応性>
ハウスダストに対する抗体を以下のようにして作製した。成熟したメス鳥(ダチョウ、
ニワトリ、ウズラ)を用いた。ハウスダストアレルゲン50μgをフロイントの完全アジ
ュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個別に5羽のダチョウ
、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリもウズラも同量の抗原
を接種したことになる。なお、ここでハウスダストアレルゲンとは、生活空間から採取さ
れたアレルゲンと考えられる物質の集合である。
<Reactivity of egg yolk antibody prepared by immunizing ostrich, chicken and quail with house dust allergen>
An antibody against house dust was prepared as follows. Mature female bird (ostrich,
Chicken, quail). The ostrich was first immunized by mixing 50 μg of house dust allergen with 0.2 mL of Freund's complete adjuvant. Each antigen was individually inoculated into 5 ostriches, 5 chickens and 5 quails. Ostriches, chickens and quails have been vaccinated with the same amount of antigen. Here, the house dust allergen is a collection of substances considered to be allergens collected from living space.

初回免疫後、2週目と4週目に50μgの抗原とフロイントの不完全アジュバントの混
和液を、各鳥に追加免疫した。初回免疫後8週目に得られた各鳥からの卵の卵黄より卵黄
抗体(IgY)を精製した。得られた卵黄抗体のダニアレルゲンおよびネコアレルゲン、
イヌアレルゲンに対する反応性をELISA(Enzyme−Linked Immun
o Sorbent Assay)により検証した。
After the first immunization, each bird was boosted with a mixture of 50 μg of antigen and Freund's incomplete adjuvant at 2 and 4 weeks. The egg yolk antibody (IgY) was purified from the egg yolk of each bird obtained 8 weeks after the first immunization. Mite allergen and cat allergen of the obtained egg yolk antibody,
Reactivity to canine allergens was determined by ELISA (Enzyme-Linked Immun.
o Sorbent Assay).

ELISAによる抗体のハウスダストアレルゲンに対する反応性は以下のようにして調
べた。96穴ELISAプレートの各穴に各ダニアレルゲン(Dfb,Dpb,Dff,
Dpf)およびネコアレルゲンnFel1,およびイヌアレルゲンnCanf1をそれぞ
れ10μgを別々に固層化した(室温で4時間)。その後、ダチョウ抗体(各3羽のダチ
ョウから得た卵黄からの抗体の混合物)、ニワトリ抗体(各3羽のニワトリから得た卵黄
からの抗体の混合物)、ウズラ抗体(各3羽のウズラから得た卵黄からの抗体の混合物)
の段階希釈液(原液は2mg/mL)を各穴に滴下し、室温で1時間反応させた。
The reactivity of the antibody to house dust allergen by ELISA was examined as follows. Each mite allergen (Dfb, Dpb, Dff,
Dpf) and cat allergen nFel1, and canine allergen nCanf1 were each separately solidified (4 hours at room temperature). Then ostrich antibody (mixture of antibodies from egg yolk obtained from each of three ostriches), chicken antibody (mixture of antibodies from egg yolk obtained from each of three chickens), quail antibody (obtained from three quails each) Mixture of antibodies from egg yolk)
(2 mg / mL stock solution) was dropped into each hole and allowed to react at room temperature for 1 hour.

洗浄後、各抗体に対するHRP標識2次抗体を室温で1時間反応させた。十分な洗浄後
、ペルオキシダーゼ用発色キット(S−Bio SUMILON)を用いてプレートリー
ダーにて吸光度(450nm)を測定した。免疫前の各鳥種の卵黄抗体の2倍以上の吸光
度値を示す最大希釈倍率をELISA値として示した。結果を表2に示す。
After washing, an HRP-labeled secondary antibody for each antibody was reacted at room temperature for 1 hour. After sufficient washing, absorbance (450 nm) was measured with a plate reader using a peroxidase coloring kit (S-Bio SUMILON). The maximum dilution factor showing the absorbance value of 2 times or more of the yolk antibody of each bird species before immunization was shown as the ELISA value. The results are shown in Table 2.

ハウスダストアレルゲンを免疫することにより、ダチョウ、ニワトリ、ウズラにダニア
レルゲン(Dfb,Dpb,Dff,Dpf)およびネコアレルゲンnFel1およびイ
ヌアレルゲンnCanf1に対する高感度の卵黄抗体が作製されることが判明した。特に
、各鳥種には同量の抗原を免疫したのにもかかわらず、巨大なダチョウが最も反応性が高
い抗体が産生された。これはダチョウを使えば、少量の抗原でも高感度の抗体が産生でき
ることを示している。
By immunizing house dust allergens, it was found that highly sensitive egg yolk antibodies against mite allergens (Dfb, Dpb, Dff, Dpf) and cat allergen nFel1 and canine allergen nCanf1 were produced in ostriches, chickens and quails. In particular, despite the immunization of each bird species with the same amount of antigen, giant ostriches produced the most reactive antibodies. This shows that if ostriches are used, highly sensitive antibodies can be produced with a small amount of antigen.

<ダチョウにハウスダストアレルゲンを免疫して作製した卵黄抗体のアレルギー反応抑
制効果>
ハウスダストアレルゲンを抗原として得た卵黄抗体の効果を調べた。ハウスダストアレ
ルゲンを染み込ませて乾燥したディスク濾紙(1ディスク中5μgのアレルゲンを含有)
(商品名:アレルゲンディスク「トリイ」ハウスダスト)に5μLのPBS(リン酸緩衝
液)、または5μLのダチョウ卵黄抗体(ダニアレルゲンDfbまたはハウスダストアレ
ルゲンを免疫して作製したもの)(15mg/mL)を添加し、室温で10分間放置した
。その後、ディスク濾紙をハウスダストアレルギー罹患ボランティアの下鼻甲介粘膜に付
け、5分間放置し、臨床症状(鼻内掻痒感、くしゃみ、水性鼻漏、粘膜腫脹)の有無を観
察し、臨床症状の症状別の発現率を算出した。結果を表3に示す。
<Allergic reaction suppression effect of egg yolk antibody prepared by immunizing ostrich with house dust allergen>
The effect of egg yolk antibody obtained using house dust allergen as an antigen was examined. Disc filter paper soaked with house dust allergen (contains 5 μg of allergen in one disc)
(Product name: Allergen disc “Torii” house dust) 5 μL PBS (phosphate buffer) or 5 μL ostrich egg yolk antibody (produced by immunizing mite allergen Dfb or house dust allergen) (15 mg / mL) And left at room temperature for 10 minutes. After that, put the disc filter paper on the lower turbinate mucosa of volunteers with house dust allergy, leave it for 5 minutes, observe the presence or absence of clinical symptoms (nasal itching, sneezing, aqueous rhinorrhea, mucosal swelling) Another expression rate was calculated. The results are shown in Table 3.

ダニアレルゲンおよびハウスダストアレルゲンを免疫して作製したダチョウ卵黄抗体に
は、アレルギー反応の低減効果が認められた。
The ostrich egg yolk antibody prepared by immunizing mite allergen and house dust allergen was found to reduce the allergic reaction.

<ダチョウ、ニワトリ、ウズラに緑膿菌ホモジネート液を免疫して作製した卵黄抗体の
反応性>
緑膿菌ホモジネート液を抗原とした抗体を以下のように作製した。成熟したメス鳥(ダ
チョウ、ニワトリ、ウズラ)を用いた。緑膿菌のホモジネート液(蛋白量50μg)をフ
ロイントの完全アジュバント0.2mLと混和し、ダチョウに初回免疫した。各抗原を個
別に5羽のダチョウ、5羽のニワトリ、5羽のウズラに接種した。ダチョウもニワトリも
ウズラも同量の抗原を接種したことになる。
<Reactivity of egg yolk antibody prepared by immunizing ostrich, chicken, quail with Pseudomonas aeruginosa homogenate>
An antibody using a Pseudomonas aeruginosa homogenate solution as an antigen was prepared as follows. Mature female birds (ostrich, chicken, quail) were used. Pseudomonas aeruginosa homogenate solution (protein amount 50 μg) was mixed with Freund's complete adjuvant 0.2 mL, and the ostrich was first immunized. Each antigen was individually inoculated into 5 ostriches, 5 chickens and 5 quails. Ostriches, chickens and quails have been vaccinated with the same amount of antigen.

初回免疫後、2週目と4週目に50μgの抗原とフロイントの不完全アジュバントの混
和液を、各鳥に追加免疫した。初回免疫後8週目に得られた各鳥からの卵の卵黄より卵黄
抗体(IgY)を精製した。得られた卵黄抗体の緑膿菌(菌体)およびセラミダーゼに対
する反応性をELISAにより検証した。
After the first immunization, each bird was boosted with a mixture of 50 μg of antigen and Freund's incomplete adjuvant at 2 and 4 weeks. The egg yolk antibody (IgY) was purified from the egg yolk of each bird obtained 8 weeks after the first immunization. The reactivity of the obtained egg yolk antibody to Pseudomonas aeruginosa (bacteria) and ceramidase was verified by ELISA.

ELISAによる抗体の緑膿菌ホモジネートに対する反応性は以下のようにして調べた
。96穴ELISAプレートの各穴に緑膿菌(菌体)およびセラミダーゼをそれぞれ10
μgを別々に固層化した(室温で4時間)。その後、ダチョウ抗体(各3羽のダチョウか
ら得た卵黄からの抗体の混合物)、ニワトリ抗体(各3羽のニワトリから得た卵黄からの
抗体の混合物)、ウズラ抗体(各3羽のウズラから得た卵黄からの抗体の混合物)の段階
希釈液(原液は2mg/mL)を各穴に滴下し、室温で1時間反応させた。
The reactivity of the antibody to Pseudomonas aeruginosa homogenate by ELISA was examined as follows. 10 Pseudomonas aeruginosa (bacteria) and ceramidase in each well of the 96-well ELISA plate
μg was layered separately (4 hours at room temperature). Then ostrich antibody (mixture of antibodies from egg yolk obtained from each of three ostriches), chicken antibody (mixture of antibodies from egg yolk obtained from each of three chickens), quail antibody (obtained from three quails each) A mixture of antibodies from egg yolks) was added dropwise to each well and allowed to react at room temperature for 1 hour.

洗浄後、各抗体に対するHRP標識2次抗体を室温で1時間反応させた。十分な洗浄後
、ペルオキシダーゼ用発色キット(S−Bio SUMILON)を用いてプレートリー
ダーにて吸光度(450nm)を測定した。免疫前の各鳥種の卵黄抗体の2倍以上の吸光
度値を示す最大希釈倍率をELISA値として示した。結果を表4に示す。
After washing, an HRP-labeled secondary antibody for each antibody was reacted at room temperature for 1 hour. After sufficient washing, absorbance (450 nm) was measured with a plate reader using a peroxidase coloring kit (S-Bio SUMILON). The maximum dilution factor showing the absorbance value of 2 times or more of the yolk antibody of each bird species before immunization was shown as the ELISA value. The results are shown in Table 4.

緑膿菌のホモジネート液を免疫することにより、ダチョウ、ニワトリ、ウズラに緑膿菌
(菌体)だけではなくセラミダーゼに対する高感度の卵黄抗体が作製されることが判明し
た。特に、各鳥種には同量の抗原を免疫したのにもかかわらず、巨大なダチョウが最も反
応性が高い抗体が産生された。これはダチョウを使えば少量の抗原でも高感度の抗体が産
生できることを示している。
By immunizing Pseudomonas aeruginosa homogenate, it was found that highly sensitive egg yolk antibodies against not only Pseudomonas aeruginosa (bacteria) but also ceramidase were produced in ostriches, chickens and quails. In particular, despite the immunization of each bird species with the same amount of antigen, giant ostriches produced the most reactive antibodies. This shows that if ostriches are used, highly sensitive antibodies can be produced with a small amount of antigen.

セラミドは皮膚の保湿やバリア機能維持に重要な働きをするが、内因性のセラミダーゼ
等によって消化される。セラミダーゼは緑膿菌等の細菌からも産生される酵素であり、皮
膚のセラミドを分解することにより病原細菌の皮膚深部への浸潤に関与する。セラミダー
ゼに対する抗体を化粧品や医薬品へ含有させることにより、セラミドの分解を抑制し、皮
膚のバリア機能や保湿性を強化、皮膚機能の正常化が図れると考えられる。
Ceramide plays an important role in moisturizing the skin and maintaining the barrier function, but is digested by endogenous ceramidase and the like. Ceramidase is an enzyme also produced from bacteria such as Pseudomonas aeruginosa, and is involved in infiltration of pathogenic bacteria into the skin by decomposing ceramide in the skin. It is considered that the inclusion of an antibody against ceramidase in cosmetics and pharmaceuticals can suppress the degradation of ceramide, enhance the skin barrier function and moisture retention, and normalize the skin function.

本発明に係る抗体は、化粧品、医薬品はもとより、除菌スプレー、芳香剤、消臭剤に含ませることができ、また加湿器に使う水に含ませることもできる。また、本発明に係る抗体は、エアコンやマスクのフィルターに担持させてもよい。   The antibody according to the present invention can be contained not only in cosmetics and pharmaceuticals, but also in sterilizing sprays, fragrances and deodorants, and can also be contained in water used in humidifiers. The antibody according to the present invention may be carried on an air conditioner or a filter of a mask.

Claims (2)

緑膿菌ホモジネート液を抗原としてダチョウの雌に接種させ、前記ダチョウの雌が産んだ卵から精製した抗体を含むセラミド分解抑制用組成物。   A composition for inhibiting ceramide degradation, comprising an antibody purified by inoculating an ostrich female with an antigen of Pseudomonas aeruginosa homogenate as an antigen, and purified from an egg laid by the ostrich female. 請求項1の抗体を含有する化粧品。   A cosmetic comprising the antibody of claim 1.
JP2017243883A 2017-12-20 2017-12-20 Allergen antibody and composition having the same Active JP6586450B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017243883A JP6586450B2 (en) 2017-12-20 2017-12-20 Allergen antibody and composition having the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017243883A JP6586450B2 (en) 2017-12-20 2017-12-20 Allergen antibody and composition having the same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013249674A Division JP6529216B2 (en) 2013-12-02 2013-12-02 Composition for suppressing sneezing by house dust

Publications (2)

Publication Number Publication Date
JP2018080177A JP2018080177A (en) 2018-05-24
JP6586450B2 true JP6586450B2 (en) 2019-10-02

Family

ID=62197946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017243883A Active JP6586450B2 (en) 2017-12-20 2017-12-20 Allergen antibody and composition having the same

Country Status (1)

Country Link
JP (1) JP6586450B2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195631B2 (en) * 1991-02-16 2001-08-06 太陽化学株式会社 Method for producing specific chicken egg antibody
JP3831155B2 (en) * 1998-08-20 2006-10-11 タカラバイオ株式会社 Ceramidase gene
EP1707211A4 (en) * 2003-11-28 2009-08-05 Takara Bio Inc Ceramidase inhibitor
JP4487051B2 (en) * 2005-08-29 2010-06-23 独立行政法人科学技術振興機構 Antibody using ostrich and production method thereof
EP2746394A4 (en) * 2011-08-19 2015-07-15 Ostrich Pharma Kk Antibody and antibody-containing composition

Also Published As

Publication number Publication date
JP2018080177A (en) 2018-05-24

Similar Documents

Publication Publication Date Title
Quirce et al. Chicken serum albumin (Gal d 5*) is a partially heat‐labile inhalant and food allergen implicated in the bird‐egg syndrome
Fernández et al. Indoor air contaminants and their impact on respiratory pathologies
Sastre et al. Allergy to cockroaches in patients with asthma and rhinitis in an urban area (Madrid)
JP2007510712A (en) Bactericidal composition and methods for making and using the same
JP2006316063A (en) Vaseline-based nasal ointment
JP6586450B2 (en) Allergen antibody and composition having the same
Kilpiö et al. Allergy to feathers
JP6529216B2 (en) Composition for suppressing sneezing by house dust
Luo et al. Effect of enriched housing on levels of natural (auto-) antibodies in pigs co-infected with porcine reproductive and respiratory syndrome virus (PRRSV) and Actinobacillus pleuropneumoniae
WO1999053763A1 (en) An environment friendly acaricide formulation
JP2017006008A (en) Antibody and antiserum against mers
JP2004538237A5 (en)
KR20100111791A (en) Cosmetic composition containing igy from egg yolk for treatment of acene
US20010051155A1 (en) Methods and compositions for decreasing allergic reactions to surface allergens
Özdemir Cockroach allergy, respiratory allergic diseases and its immunotherapy
US20030118670A1 (en) Novel composition and method for altering allergenic protein in the environment
CN114470198B (en) IgY spray of SARS-CoV-2 egg yolk neutralization antibody for preventing and treating new coronal pneumonia
Sybilski et al. The effects of disease awareness on lifestyle changes and the use of preventive measures in asthma patients.
Catcott Effects of air pollution on animals
JPWO2015083375A1 (en) ANTIBODY, COMPOSITION, AND PRODUCTION METHOD USING AN AGENT
JP6200630B2 (en) Pharmaceutical composition
Bergmann et al. The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge
Squillace Environmental control
Obol et al. Possession, attitudes and perceptions of insecticide-treated bed nets among pregnant women in a post conflict district in Northern Uganda
Chapman et al. Cockroach allergens, environmental exposure, and asthma

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180828

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20181226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190528

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190820

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190909

R150 Certificate of patent or registration of utility model

Ref document number: 6586450

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250